Beth Stavola, Chief Strategy Officer of iAnthus (CNSX: IAN) and the founder of MPX Bioceuticals, joins The Dales Report in Miami for a 3-part exclusive interview series. In the first episode, Beth talks about how iAnthus is positioned for success after a period of significant growth and what are the new markets to watch in the year ahead.
